Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

Por Dearnaley, D P, Hall, E, Lawrence, D, Huddart, R A, Eeles, R, Nutting, C M, Gadd, J, Warrington, A, Bidmead, M, Horwich, A
Publicado em 2005

The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition

Por Singhal, N. K., Huang, H., Li, S., Clements, R., Gadd, J., Daniels, A., Kooijman, E. E., Bannerman, P., Burns, T., Guo, F., Pleasure, D., Freeman, E., Shriver, L., McDonough, J.
Publicado no Exp Brain Res (2016)

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone

Por O'Sullivan, J M, McCready, V R, Flux, G, Norman, A R, Buffa, F M, Chittenden, S, Guy, M, Pomeroy, K, Cook, G, Gadd, J, Treleaven, J, Al-Deen, A, Horwich, A, Huddart, R A, Dearnaley, D P
Publicado em 2002